Expert Review of Neurotherapeutics

Global impact of schizophrenia
pp. 1-4(4)
Author: Johnson, Dale L

News in Brief
pp. 5-8(4)

Mental and Behavioral Dysfunction in Movement Disorders: An International Symposium
pp. 9-11(3)
Author: Rektorova, Irena

‘Atypical’ antipsychotics: where does ziprasidone fit?
pp. 13-24(12)
Author: Remington, Gary

Hormone treatment for mood disorders in women
pp. 25-34(10)
Authors: Soares, Claudio N; Poitras, Jennifer R; Prouty, Jennifer

Factors affecting the use and selection of antidepressants in the elderly
pp. 35-43(9)
Author: Kehoe, William A

Management of pediatric disruptive disorders
pp. 45-51(7)
Author: Lindsay, Ronald L

Prenatal risk factors and schizophrenia
pp. 53-60(8)
Author: Brown, Alan S

New targets for antipsychotics
pp. 61-68(8)
Authors: Jones, Hugh M; Pilowsky, Lyn S

Atypical antipsychotics: revolutionary or incremental advance?
pp. 69-88(20)
Authors: Citrome, Leslie; Volavka, Jan

Therapeutic potential of nervous system growth factors for neurodegenerative disease
pp. 89-96(8)
Authors: Merrill, David A; Blesch, Armin; Tuszynski, Mark H

Management of Parkinson’s disease
pp. 97-104(8)
Author: Colcher, Amy

Adverse effects in the treatment of Parkinson’s disease
pp. 105-118(14)
Author: Singer, Carlos

Pharmacological approaches to the treatment of excessive drinking and alcohol dependence
pp. 119-125(7)
Author: Drummond, Colin

Behavioral treatment of insomnia
pp. 127-137(11)
Authors: Means, Melanie K; Edinger, Jack D